Cartilage oligomeric matrix protein is a natural inhibitor of thrombin
Authors:
- 13 August 2015
- journal article
- Published by American Society of Hematology in Blood
- Vol. 126 (7) , 905-914
Abstract
Thrombin is an effector enzyme for hemostasis and thrombosis; however, endogenous regulators of thrombin remain elusive. Cartilage oligomeric matrix protein (COMP), a matricellular protein also known as thrombospondin-5, is essential for maintaining vascular homeostasis. Here, we asked whether COMP is involved in the process of blood coagulation. COMP deficiency shortened tail-bleeding and clotting time and accelerated ferric-chloride–induced thrombosis in mice. The absence of COMP had no effect on platelet count. In contrast, COMP specifically inhibited thrombin-induced platelet aggregation, activation, and retraction and the thrombin-mediated cleavage of fibrinogen. Furthermore, surface plasmon resonance analysis revealed direct thrombin-COMP binding (KD = 1.38 ± 0.24 μM). In particular, blockage of thrombin exosites with compounds specific for exosite I (hirudin and HD1 aptamer) or exosite II (heparin and HD22 aptamer) impaired the COMP-thrombin interaction, indicating a 2-site binding mechanism. Additionally, epidermal growth factor–like repeats (amino acids 84-261) were identified as a COMP binding site for thrombin. Moreover, COMP was expressed in and secreted by platelets. Using bone marrow transplantation and platelet transfusion to create chimeric mice, platelet-derived but not vessel-wall–derived COMP was demonstrated to inhibit coagulation. Taken together, COMP is an endogenous thrombin inhibitor and negative regulator of hemostasis and thrombosis. Key Points COMP negatively regulates hemostasis and thrombosis. COMP is a natural inhibitor of thrombin.Keywords
This publication has 38 references indexed in Scilit:
- Deficiency of cartilage oligomeric matrix protein causes dilated cardiomyopathyBasic Research in Cardiology, 2013
- Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent MannerPLOS ONE, 2013
- Thrombospondins in physiology and disease: New tricks for old dogsMatrix Biology, 2012
- Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studiesThe Lancet, 2011
- Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivoJournal of Experimental Medicine, 2009
- Macrophage deficiency of p38α MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in miceJournal of Clinical Investigation, 2009
- Exosites in the substrate specificity of blood coagulation reactionsJournal of Thrombosis and Haemostasis, 2007
- Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivoBlood, 2006
- ADAMTS‐7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix proteinThe FASEB Journal, 2006
- Megakaryocytes require thrombospondin-2 for normal platelet formation and functionBlood, 2003